Azienda Ospedaliero-Universitaria Sant Andre

At Azienda Ospedaliero-Universitaria Sant Andre in Rome, cardiovascular research is a major focus, spanning atrial fibrillation, heart failure, hypertension, myocardial infarction, and hypertrophic cardiomyopathy. These studies are designed to test new treatment options, improve risk reduction, and evaluate better ways to manage serious heart and blood vessel conditions.

• High-risk cardiovascular disease and prevention of major events
• Atrial fibrillation and stroke prevention
• Heart failure, cardiomyopathy, and blood pressure control

Much of the work centers on improving long-term outcomes for patients with complex cardiovascular disease, including those with elevated lipid levels or inflammatory risk.

This site conducts extensive research in multiple sclerosis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, and related neuromuscular diseases. The trials aim to assess new therapies, support symptom control, and measure whether treatments can slow disability progression or improve daily function.

• Multiple sclerosis and relapse control
• Generalized and ocular myasthenia gravis
• Peripheral neuropathies and muscle disorders

Research in this area often focuses on immune-mediated conditions, reflecting a strong interest in therapies that can change the course of chronic neurologic disease.

Clinical trials in hematologic malignancies are a prominent part of the portfolio, including acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, multiple myeloma, and myelodysplastic syndromes. The research is aimed at improving remission rates, reducing relapse, and identifying more effective treatment strategies for patients with advanced blood cancers.

• Leukemia treatment optimization and molecular response
• Relapsed or refractory multiple myeloma
• Myelofibrosis and myelodysplastic syndromes

These studies often explore whether newer therapies can improve outcomes in patients who have limited options after prior treatment.

The site also supports cancer research across several solid tumors, including breast cancer, prostate cancer, bladder cancer, and neuroendocrine tumors. Trials in this area are focused on testing new treatment combinations, delaying disease progression, and improving response in patients with early-stage, advanced, or recurrent disease.

• Breast cancer and hormone receptor-positive disease
• Prostate cancer with high risk of progression
• Gastroenteropancreatic and thoracic neuroendocrine tumors

Research includes both targeted therapies and treatment strategies intended to strengthen disease control while maintaining tolerability.

Several trials address immune system diseases and inflammatory conditions such as thyroid eye disease, dermatomyositis, myositis, idiopathic inflammatory myopathy, and eosinophilic asthma. The purpose is to evaluate therapies that may reduce inflammation, improve symptoms, and provide better long-term disease control.

• Autoimmune muscle and nerve disorders
• Thyroid-related eye disease
• Severe inflammatory and allergic airway disease

These studies reflect a strong interest in conditions where the immune system plays a central role in ongoing tissue damage and symptom burden.

Research in psychiatry includes major depressive disorder, treatment-resistant schizophrenia, psychosis associated with Alzheimer’s disease, and substance use disorder. The trials are designed to test new approaches for improving mood, reducing psychiatric symptoms, and helping patients who have not responded well to standard care.

• Depression in adults and older patients
• Schizophrenia with limited treatment response
• Behavioral and psychiatric symptoms in neurodegenerative disease

This area highlights efforts to expand treatment options for complex mental health conditions with significant impact on daily functioning.

The site is active in respiratory disease research, including chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, bronchiectasis, and asthma. These trials aim to assess new treatments that may improve breathing, slow disease worsening, and reduce the burden of chronic lung disease.

• Chronic obstructive and fibrotic lung disease
• Severe eosinophilic asthma
• Long-term control of progressive pulmonary conditions

Much of this work focuses on conditions with limited therapeutic options and substantial impact on quality of life.

Trials in endocrinology and metabolic disease include Graves’ disease, Cushing’s disease, diabetes mellitus, hypercholesterolemia, chronic kidney disease, and transthyretin amyloidosis. The research is aimed at improving disease control, lowering cardiovascular risk, and exploring new ways to support patients with complex metabolic and hormonal disorders.

• Thyroid and adrenal hormone disorders
• Cholesterol management and kidney-related risk
• Amyloid-related cardiometabolic disease

These studies often connect metabolic health with broader cardiovascular and organ-protection goals.

Research in eye diseases includes glaucoma, ocular hypertension, neovascular age-related macular degeneration, postoperative inflammation after cataract surgery, and thyroid eye disease. The trials are intended to evaluate treatments that may preserve vision, reduce inflammation, and improve eye pressure control.

• Glaucoma and ocular pressure management
• Retinal disease and vision preservation
• Inflammation after eye surgery

This area combines chronic disease management with efforts to protect sight and improve patient comfort.

The site also studies musculoskeletal diseases and pain-related conditions such as chronic low back pain, low back pain, idiopathic or diabetic gastroparesis, myotonic dystrophy type 1, and facioscapulohumeral muscular dystrophy. These trials generally aim to improve symptom relief, physical function, and overall daily well-being.

• Chronic pain and functional limitation
• Inherited muscle disorders
• Digestive motility problems with chronic symptoms

Research here reflects a broad effort to address conditions that can significantly affect mobility, comfort, and independence.